Action NOVOB NOVO NORDISK A/S
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués Novo Nordisk A/S SIX SWISS EXCHANGE - BLUE CHIPS SEGMENT

Actions

NOVOB

DK0060102614

Cours en clôture SIX SWISS EXCHANGE - BLUE CHIPS SEGMENT
Autres places de cotation
- DKK - Graphique intraday de Novo Nordisk A/S
09:03 Chassez la convoitise, elle revient au galop Our Logo
06:37 La Chine approuve l'injection de Novo Nordisk pour la gestion du poids à long terme MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline
GL
Novo Nordisk A/S - share repurchase programme
GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month
AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association
GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says
AQ
Novo Nordisk A/S - share repurchase programme
GL
Haemophilia drug could reduce treated bleeding episodes
AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)
AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development
AQ
Novo Nordisk A/S - share repurchase programme
GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
AQ
Novo Nordisk A/S - share repurchase programme
GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
AQ
Novo Nordisk A/S - share repurchase programme
GL
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
AQ
Novo Nordisk A/S - share repurchase programme
GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GL
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial
GL
Tampere University : Novo Nordisk Foundation grants 670 000 EUR to develop organ transplant assessment and drug discovery tool for epilepsy
AQ
Equity Research | NANEXA: Insights from CMD underscore near- to mid-term opportunities with significant potential
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action NOVO B
  4. Action NOVOB
  5. Actualités Novo Nordisk A/S
  6. Communiqués